Team:Goettingen/project overview/perspectives

From 2014.igem.org

(Difference between revisions)
Line 17: Line 17:
<br />
<br />
<br />
<br />
-
<p>There are two main milestones as far as our project is concerned. First,is the generation of peptides with an affinity to fungal surface molecules and second, is the  proof of principle that our selection scheme can be used to generate peptides with affinity to a molecule under scrutiny. Both milestones hold promise but before that, we'd like to elaborate on the future scope of the first milestone since it bears relevance to medicine and healthcare.</p><br />
+
<p>We have attained two milestones as far as the applications of our project is concerned. First,is the generation of peptides with an affinity to fungal surface molecules and second, is the  proof of principle that our selection scheme can be used to generate peptides with affinity to a molecule under scrutiny. Both milestones hold promise but before that, we would like to elaborate on the future scope of the first milestone since it bears relevance to medicine and healthcare.</p><br />
       <script>
       <script>
       window.fbAsyncInit = function() {
       window.fbAsyncInit = function() {

Revision as of 16:37, 19 September 2014

12/15



Further perspectives



We have attained two milestones as far as the applications of our project is concerned. First,is the generation of peptides with an affinity to fungal surface molecules and second, is the proof of principle that our selection scheme can be used to generate peptides with affinity to a molecule under scrutiny. Both milestones hold promise but before that, we would like to elaborate on the future scope of the first milestone since it bears relevance to medicine and healthcare.




12/15